From the RSNA refresher courses: State-of-the-art adrenal imaging

Radiographics

Volumn 21, Issue 4, 2001, Pages 995-1012

  Mayo Smith, William W ^a   Boland, Giles W ^b   Noto, Richard B ^a   Lee, Michael J ^c  

^a BROWN UNIVERSITY   (United States)

^b HARVARD UNIVERSITY   (United States)

^c BEAUMONT HOSPITAL   (Ireland)

Author keywords

Adrenal gland, biopsy, 86.1261; Adrenal gland, CT, 86.1211; Adrenal gland, MR, 86.121414; Adrenal gland, neoplasms, 86.317, 86.328, 86.33

Indexed keywords

ADRENAL DISEASE; ADRENAL TUMOR; ALGORITHM; BIOPSY; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; HUMAN; REVIEW;

ADRENAL GLAND DISEASES; ADRENAL GLAND NEOPLASMS; ALGORITHMS; BIOPSY; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC IMAGING; HUMANS;

EID: 0035405945     PISSN: 02715333     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiographics.21.4.g01jl21995     Document Type: Article

References (65)

1. Abrams HL, Siegelman SS, Adams DF, et al. Computed tomography versus ultrasound of the adrenal gland: a prospective study. Radiology 1982; 143:121-128.
2. Witteles RM, Kaplan EL, Roizen MF. Sensitivity of diagnostic and localization tests for pheochromocytoma in clinical practice. Arch Intern Med 2000; 160:2521-2524.
3. Bravo EL, Gifford RW. Current concepts: pheochromocytoma - diagnosis localization and management. N Engl J Med 1984; 311:1298-1303.
4. Siperstein AE, Berber E, Engle KL, Duh QY, Clark OH. Laparoscopic posterior adrenalectomy: technical considerations. Arch Surg 2000; 135: 967-971.
5. Krebs TL, Wagner BJ. MR imaging of the adrenal gland: radiologic-pathologic correlation. Radio-Graphics 1998; 18:1425-1440.
6. Varghese JC, Hahn PF, Papanicolau N, Mayo-Smith WW, Gaa JA, Lee MJ. MR differentiation of pheochromocytoma from other adrenal lesions based on qualitative analysis of T2 relaxation times. Clin Radiol 1997; 52:603-606.
7. Shapiro B, Copp JE, Sisson JC, Eyre PL, Wallis J, Beierwaltes WH. Iodine-131 metaiodobenzylguanidine for the locating of suspected pheochromocytoma: experience in 400 cases. J Nucl Med 1985; 26:576-585.
8. Maurea S, Cuocolo A, Reynolds JC, et al. Iodine-131-metaiodobenzylguanidine scintigraphy in preoperative and postoperative evaluation of paragangliomas: comparison with CT and MRI. J Nucl Med 1993; 34:173-179.
9. Freitas JE. Adrenal cortical and medullary imaging. Semin Nucl Med 1995; 25:235-250.
10. Krenning EP, Kwekkeboom DJ, Pauwels S, Kvols LK, Reubi JC. Somatostatin receptor scintigraphy. In: Freeman LM, ed. Nuclear Medicine Annual 1995. New York, NY: Raven, 1995; 1-50.
11. Dallman MF, Akana SF, Levin N, et al. Corticosteroids and the control of function in the hypothalamo-pituitary-adrenal (HPA) axis. Ann N Y Acad Sci 1994 746:22-31.
12. Sohaib SA, Hanson JA, Newell-Price JDC, et al. CT appearance of the adrenal glands in adrenocorticotrophic hormone-dependent Cushing's syndrome. AJR Am J Roentgenol 1999; 172:997-1002.
13. Kaye TB, Crapo L. The Cushing syndrome: an update on diagnostic tests. Ann Intern Med 1990 112:434-444.
14. Freitas JE, Henvig KR, Cerny JC, Beierwaltes WH. Preoperative localization of adrenal remnants. Surg Gynecol Obstet 1977; 145:705-708.
15. Dunnick NR. Adrenal imaging: current status. AJR Am J Roentgenol 1990; 154:927-936.
16. Dunnick NR, Leight GS, Robidoux MA, Leder RA, Paulson E, Kurylo L. CT in the diagnosis of primary aldosteronism: sensitivity in 29 patients. AJR Am J Roentgenol 1993; 160:321-324.
17. Ikeda DM, Francis IR, Glazer GM, Amendola MA, Gross MD, Aisen AM. The detection of adrenal tumors and hyperplasia in patients with primary aldosteronism: comparison of scintigraphy, CT and MR imaging. AJR Am J Roentgenol 1989; 153:301-306.
18. Glazer HS, Weyman PJ, Sagal SS, Levitt RG, McClennan BL. Adrenal masses: incidental discovery on computed tomography. AJR Am J Roentgenol 1982; 139:81-85.
19. Dunnick NR, Korobkin M, Francis I. Adrenal radiology: distinguishing benign from malignant masses. AJR Am J Roentgenol 1996; 167:861-867.
20. Abrams HL, Spiro R, Goldstein N. Metastases in carcinoma: analysis of 1000 autopsied cases. Cancer 1950; 3:74-85.
21. Francis IR, Smid A, Gross MD, Shapiro B, Naylor B, Glazer GM. Adrenal masses in oncologic patients: function and morphologic evaluation. Radiology 1988; 166:353-356.
22. Korobkin M, Giordano TJ, Brodeur FJ, et al. Adrenal adenomas: relationship between histologic lipid and CT and MR findings. Radiology 1996; 200:743-747.
23. Lee MJ, Hahn PF, Papanicolaou N, et al. Benign and malignant adrenal masses: CT distinction with attenuation coefficients, size, and observer analysis. Radiology 1991; 179:415-418.
24. Korobkin M, Brodeur FJ, Yutzy GG, et al. Differentiation of adrenal adenomas from nonadenomas using CT attenuation values. AJR Am J Roentgenol 1996; 166:531-536.
25. Boland GW, Lee MJ, Gazelle GS, Halpern EF, McNicholas MM, Mueller PR. Characterization of adrenal masses using unenhanced CT: an analysis of the CT literature. AJR Am J Roentgenol 1998; 171:201-204.
26. Caoili EM, Korobkin M, Francis IR, Cohan RH, Dunnick NR. Delayed enhanced CT of lipid poor adrenal adenomas. AJR Am J Roentgenol 2000; 175:1411-1415.
27. Pena CS, Boland GW, Hahn PF, Lee MJ, Mueller PR. Characterization of indeterminate (lipid-poor) adrenal masses: use of washout characteristics at contrast-enhanced CT. Radiology 2000; 217:798-802.
28. Korobkin M, Brodeur FJ, Francis IR, Quint LE, Dunnick NR, Goodsitt M. Delayed enhanced CT for differentiation of benign from malignant adrenal masses. Radiology 1996; 200:737-742.
29. Szolar DH, Kammerhuber FH. Quantitative CT evaluation of adrenal gland masses: a step forward in the differentiation between adenomas and non-adenomas? Radiology 1997; 202:517-521.
30. Boland GW, Hahn PF, Pena C, Mueller PR. Adrenal masses: characterization with delayed contrast-enhanced CT. Radiology 1997; 202:693-696.
31. Korobkin M, Brodeur FJ, Francis IR, Quint LE, Dunnick NR, Londy F. CT time-attenuation washout curves of adrenal adenomas and nonadenomas. AJR Am J Roentgenol 1998; 170:747-752.
32. Szolar DH, Kammerhuber FH. Adrenal adenomas and nonadenomas: assessment of washout at delayed contrast-enhanced CT. Radiology 1998; 207:369-375.
33. Krestin GP, Friedmann G, Fishbach R, Neufant KFR, Allolio B. Evaluation of adrenal masses in oncologic patients: dynamic contrast-enhanced MR vs CT. J Comput Assist Tomogr 1991; 15: 104-110.
34. Ichikawa T, Ohtomo K, Uchiyama G, Fujimoto H, Nasu K. Contrast-enhanced dynamic MRI of adrenal masses: classification of characteristic enhancement patterns. Clin Radiol 1995; 50:295-300.
35. Mitchell DG, Crovello M, Matteucci T, Peterson RO, Miettinen MM. Benign adrenocortical masses: diagnosis with chemical shift MR imaging. Radiology 1992; 185:345-351.
36. Reinig JW, Stutley JE, Leonhurdt CM, Spicer KM, Margolis M, Caldwell CB. Differentiation of adrenal masses with MR imaging: comparison of techniques. Radiology 1994; 192:41-46.
37. Schwartz LH, Panicek DM, Louthcer JA, et al. Adrenal masses in patients with malignancy: prospective comparison of echo-planar, fast spin-echo and chemical-shift MR imaging. Radiology 1995; 197:421-425.
38. Lee MJ, Mayo-Smith WW, Hahn PF, et al. State-of-the-art MR imaging of the adrenal gland. RadioGraphics 1994; 14:1015-1029.
39. Semelka RC, Shoenut JP, Lawrence PH, et al. Evaluation of adrenal masses with gadolinium enhancement and fat-suppressed MR imaging. J Magn Reson Imaging 1993; 3:337-343.
40. Chezmar JL, Robbins SM, Nelson R, Steinberg HV, Torres WE, Bernardino ME. Adrenal masses: characterization using MR imaging. Radiology 1988; 166:357-359.
41. Outwater EK, Siegelman ES, Huang AB, Birnbaum BA. Adrenal masses: correlation between CT attenuation value and chemical shift ratio at MR imaging with in-phase and opposed-phase sequences. Radiology 1996; 200:749-752. [Erratum: Radiology 1996; 201:880]
42. Mayo-Smith WW, Lee MJ, McNicholas MM, Hahn PF, Boland GW, Saini S. Characterization of adrenal masses (<5 cm) by use of chemical shift MR imaging: observer performance versus quantitative measures. AJR Am J Roentgenol 1995; 165: 91-95.
43. Bilbey JH, McLoughlin RF, Kurkjian PS, et al. MR imaging of adrenal masses: volume of chemical-shift imaging for distinguishing adenomas from other tumors. AJR Am J Roentgenol 1995; 164: 637-642.
44. Outwater EK, Siegelman ES, Radecki PD, Piccoli CW, Mitchell DG. Distinction between benign and malignant adrenal masses: value of T1-weighted chemical-shift MR imaging. AJR Am J Roentgenol 1995; 165:579-583.
45. Korobkin M, Lombardi TJ, Aisen AM, et al. Characterization of adrenal masses with chemical-shift and gadolinium-enhanced MR imaging. Radiology 1995; 197:411-418.
46. Tsushima Y, Ishizaka H, Matsumoto M. Adrenal masses: differentiation with chemical-shift, fast low-angle shot MR imaging. Radiology 1993; 186: 705-709.
47. Heinz-Peer G, Honigschnabl S, Schneider B, Niederle B, Kaserer K, Lechner G. Characterization of adrenal masses using MR imaging with histopathologic correlation. AJR Am J Roentgenol 1999; 173:15-22.
48. Schwartz LH, Macari H, Huvos AG, Panicek DM. Collision tumors of the adrenal gland: demonstration and characterization on MR imaging. Radiology 1996; 201:757-760.
49. McNicholas MM, Lee MJ, Mayo-Smith WW, Hahn PF, Boland GW, Mueller PR. An imaging algorithm for the differential diagnosis of adrenal adenomas and metastases. AJR Am J Roentgenol 1995; 165:1453-1459.
50. Schwartz LH, Ginsberg MS, Burt ME, et al. MRI as an alternative to CT-guided biopsy of adrenal masses in patients with lung cancer. Ann Thorac Surg 1998; 65:193-197.
51. Boland GW, Goldberg MA, Lee MJ, et al. Indeterminate adrenal mass in patients with cancer: evaluation at PET with 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology 1995; 194:131-134.
52. Erasmus JJ, Patz EF Jr, McAdams HP, et al. Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-fluorodeoxyglucose positron emission tomography. AJR Am J Roentgenol 1997; 168:1357-1360.
53. Maurea S, Mainolfi C, Bazzicalupo L, et al. Imaging of adrenal tumors using FDG PET: comparison of benign and malignant lesions. AJR Am J Roentgenol 1999; 173:25-29.
54. Shulkin BL, Thompson NW, Shapiro B, Francis IR, Sisson JC. Pheochromocytomas: imaging with 2-[fluorine-18]fluoro-2-deoxy-D-glucose PET. Radiology 1999; 212:35-41.
55. Welch TJ, Sheedy PF II, Stephens DH, Johnson CM, Swensen SJ. Percutaneous adrenal biopsy: review of a 10-year experience. Radiology 1994; 193:341-344.
56. Silverman SG, Mueller PR, Pinkney LP, Koenker RM, Seltzer SE. Predictive value of image-guided adrenal biopsy: analysis of results of 101 biopsies. Radiology 1993; 187:715-718.
57. Doppman JL, Gill JR Jr, Nienhuis AW, Earll JM, Long JA Jr. CT findings in Addison's disease. J Comput Assist Tomogr 1982; 6:757-761.
58. Kawashima A, Sandier CM, Fishman EK, et al. Spectrum of CT findings in nonmalignant disease of the adrenal gland. RadioGraphics 1998; 18: 393-412.
59. Pommier RF, Brennan MF. An eleven-year experience with adrenocortical carcinoma. Surgery 1992; 112:963-971.
60. Kenney PJ, Wagner BJ, Rao P, Heffess CS. Myelolipoma: CT and pathologic features. Radiology 1998; 208:87-95.
61. Otal P, Escourrou G, Mazerolles C, et al. Imaging features of uncommon adrenal masses with histopathologic correlation. RadioGraphics 1999; 19:569-581.
62. Burks DW, Mirvis SE, Shanmuganathan K. Acute adrenal injury after blunt abdominal trauma: CT findings. AJR Am J Roentgenol 1992; 158:503-507.
63. Kawashima A, Sandler CM, Ernst RD, et al. Imaging of nontraumatic hemorrhage of the adrenal gland. RadioGraphics 1999; 19:949-963.
64. Glazer HS, Lee JKT, Balfe DM, Mauro MA, Griffith R, Sagel SS. Non-Hodgkin lymphoma: computed tomographic demonstration of unusual extranodal involvement. Radiology 1983; 149:211-217.
65. Tung GA, Pfister RC, Papanicolaou N, Yoder IC. Adrenal cysts: imaging and percutaneous aspiration. Radiology 1989; 173:107-110.